Nancy Miller-Rich - May 23, 2022 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Director
Signature
/s/ August J. Moretti, Attorney-in-Fact for Nancy Miller-Rich
Stock symbol
FDMT
Transactions as of
May 23, 2022
Transactions value $
$0
Form type
4
Date filed
5/25/2022, 07:02 PM
Previous filing
Nov 9, 2021
Next filing
May 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Award $0 +22.5K $0.00 22.5K May 23, 2022 Common Stock 22.5K $7.77 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Automatically granted pursuant to the terms of the Company's non-employee director compensation program.
F2 The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).